1700亿，全球最大“药+妆”公司易主

Core Viewpoint - Walgreens Boots Alliance (WBA) has completed its acquisition by Sycamore Partners, marking a significant change in ownership for the world's largest "pharmacy + beauty" company, which will be split into five independent private companies for operation [1][2][4]. Group 1: Acquisition Details - The acquisition deal was finalized at a price of approximately 170 billion yuan, with Sycamore agreeing to pay $11.45 per share in cash for WBA [2][4]. - Following the acquisition, WBA's common stock will cease trading and will no longer be listed on NASDAQ [4]. - In addition to the cash payment, WBA shareholders will receive a non-transferable right to receive up to $3 per share from the future net proceeds of WBA's VillageMD business [4]. Group 2: Company Structure Post-Acquisition - WBA will be divided into five independent companies: Walgreens, Boots Group, Shields Health Solutions, CareCentrix, and VillageMD [4][12]. - Mike Motz has been appointed as the CEO of Walgreens, bringing extensive retail experience to the role [5]. Group 3: Financial Performance - For the third quarter of fiscal year 2025, WBA reported sales of $38.986 billion, a year-over-year increase of 7.2%, but also a net loss of $1.75 billion [8][10]. - Over the first nine months of fiscal year 2025, WBA's sales reached $117.034 billion, with a net loss of $3.293 billion, a 40.52% reduction compared to the same period in the previous year [10]. Group 4: Historical Context and Market Position - WBA was formed in 2014 through the merger of Walgreens and Alliance Boots, and has faced significant challenges, including a 60% drop in stock price in 2024 [11]. - The company has accumulated losses exceeding $11.9 billion over the past 21 months, indicating ongoing financial difficulties [10]. Group 5: Boots' Market Strategy - Boots, as part of the independent structure, will continue to operate under the leadership of CEO Ornella Barra and focus on expanding its presence in the UK and international markets [14][15]. - Boots has seen a sales increase of 7.8% in its international department, indicating a positive growth trajectory [15].